Found: 39
Select item for more details and to access through your institution.
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 498, doi. 10.3390/biomedicines12030498
- By:
- Publication type:
- Article
European value-based healthcare benchmarking: moving from theory to practice.
- Published in:
- European Journal of Public Health, 2024, v. 34, n. 1, p. 44, doi. 10.1093/eurpub/ckad181
- By:
- Publication type:
- Article
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184481
- By:
- Publication type:
- Article
Androgen receptor in breast cancer: The “5W” questions.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.977331
- By:
- Publication type:
- Article
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3925, doi. 10.3390/cancers14163925
- By:
- Publication type:
- Article
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8590, doi. 10.3390/ijms23158590
- By:
- Publication type:
- Article
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07143-1
- By:
- Publication type:
- Article
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 433, doi. 10.3390/curroncol29020039
- By:
- Publication type:
- Article
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1211, doi. 10.3390/jpm11111211
- By:
- Publication type:
- Article
Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1242, doi. 10.3390/biomedicines9091242
- By:
- Publication type:
- Article
CAR T cells targeting options in th.
- Published in:
- Panminerva Medica, 2021, v. 63, n. 1, p. 37, doi. 10.23736/S0031-0808.20.04146-4
- By:
- Publication type:
- Article
Are we ready to use TMB in breast cancer clinical practice?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2490, doi. 10.3390/cancers12092490
- By:
- Publication type:
- Article
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2<sup>+</sup> Early-stage Breast Cancer?
- Published in:
- 2020
- By:
- Publication type:
- letter
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 573, doi. 10.3390/diagnostics10080573
- By:
- Publication type:
- Article
Immunotherapy: The end of the "dark age" for metastatic triple‐negative breast cancer?
- Published in:
- Breast Journal, 2020, v. 26, n. 4, p. 739, doi. 10.1111/tbj.13662
- By:
- Publication type:
- Article
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919888999
- By:
- Publication type:
- Article
Single shot ultrasound-guided thoracic paravertebral block for opioid-free radical mastectomy: a prospective observational study.
- Published in:
- Journal of Pain Research, 2019, v. 12, p. 2701, doi. 10.2147/JPR.S211944
- By:
- Publication type:
- Article
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?
- Published in:
- 2019
- By:
- Publication type:
- Letter
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/1393505
- By:
- Publication type:
- Article
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
- Published in:
- 2019
- By:
- Publication type:
- letter
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 3083, doi. 10.2147/CMAR.S137772
- By:
- Publication type:
- Article
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00137
- By:
- Publication type:
- Article
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy.
- Published in:
- International Journal of Experimental Pathology, 2017, v. 98, n. 5, p. 289, doi. 10.1111/iep.12253
- By:
- Publication type:
- Article
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Progress with palbociclib in breast cancer: latest evidence and clinical considerations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 83, doi. 10.1177/1758834016677961
- By:
- Publication type:
- Article
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 1, p. 79, doi. 10.1007/s10549-016-3923-8
- By:
- Publication type:
- Article
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 4, p. e425, doi. 10.5301/jbm.5000163
- By:
- Publication type:
- Article
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 1, p. 57, doi. 10.1007/s10549-015-3423-2
- By:
- Publication type:
- Article
Benefit from anthracyclines in relation to biological profiles in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 2, p. 307, doi. 10.1007/s10549-013-2819-0
- By:
- Publication type:
- Article
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 6, p. 10683, doi. 10.3390/ijms140610683
- By:
- Publication type:
- Article
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 775, doi. 10.1007/s10549-010-1257-5
- By:
- Publication type:
- Article
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 871, doi. 10.1007/s00280-009-1092-8
- By:
- Publication type:
- Article
Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.
- Published in:
- BMC Cancer, 2006, v. 6, p. 76, doi. 10.1186/1471-2407-6-76
- By:
- Publication type:
- Article